Bone Biologics (BBLG) Net Shares Issued and Repurchased (2014 - 2025)
Powered by 
Analysis
Bone Biologics (BBLG) Net Shares Issued and Repurchased (2014 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | - |
| 10 | Bone Biologics | 1.00 Mn | 1.00 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 55,461.00 |
| Mar 31, 2025 | 81,165.00 |
| Dec 31, 2024 | 27,641.00 |
| Mar 31, 2024 | 45,515.00 |
| Dec 31, 2023 | 32,400.00 |
| Mar 31, 2023 | 56,625.00 |
| Dec 31, 2022 | 887.00 |
| Mar 31, 2022 | 101,166.00 |
| Dec 31, 2021 | 48,847.00 |
| Dec 31, 2019 | 332,512.00 |
| Mar 31, 2019 | 54,909.00 |
| Dec 31, 2018 | 5,222.00 |
| Mar 31, 2018 | 52,218.00 |
| Dec 31, 2017 | 427,064.00 |
| Mar 31, 2017 | 80,341.00 |
| Dec 31, 2016 | 6.36 Mn |
| Mar 31, 2016 | 6.36 Mn |
| Dec 31, 2015 | 5.54 Mn |
| Dec 31, 2014 | 757,977.00 |